[Orchitis and male infertility].
Infections and inflammations of the genital tract are considered the most frequent causes of reduced male fertility, but conclusive epidemiological data are not available. In view of the exposure of germ cells to pathogenic components as well as the cells and mediators involved in the inflammatory processes, irreversible damage to spermatogenesis and corresponding decline of ejaculate quality are to be expected, particularly in cases of chronic orchitis. While the consequences of orchitis and epididymo-orchitis that exhibit clinical symptoms due to systemic or local infections are well known, including testicular atrophy and complete loss of fertility, those cases of inflammatory reactions of the testicles that manifest an asymptomatic or subclinical course, or are not even due to an infection, have received little attention until now. However, systematic histopathological analyses have shown a high prevalence of asymptomatic inflammatory reactions in testicular biopsies from infertile men. The mostly focal lymphocytic infiltrates correlate with the degree of damage to spermatogenesis and corresponding clinical and endocrinological parameters of testicular function. Noninvasive diagnostic techniques are not yet available so that chronic asymptomatic inflammations of the testicles as the primary cause or cofactor of male fertility disorders are underestimated. Except for administration of pathogen-specific antibiotics, treatment recommendations are to a large extent still lacking.
Schuppe
H-C
HC
Klinik und Poliklinik für Urologie, Kinderurologie und Andrologie, Justus-Liebig-Universität Giessen, Gaffkystrasse 14, 35385, Giessen, Deutschland. Hans-Christian.Schuppe@derma.med.uni-giessen.de
Pilatz
A
A
Hossain
H
H
Meinhardt
A
A
Bergmann
M
M
Haidl
G
G
Weidner
W
W
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001284:Atrophy; D001424:Bacterial Infections / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D001706:Biopsy; D002908:Chronic Disease; D003937:Diagnosis, Differential; D004823:Epididymitis / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007248:Infertility, Male / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D009920:Orchitis / Q000145:classification / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D011379:Prognosis; D013091:Spermatogenesis / Q000187:drug effects / Q000502:physiology; D013737:Testis / Q000473:pathology / Q000503:physiopathology; D018616:Ultrasonography, Doppler, Duplex
D000900:Anti-Bacterial Agents
Urologe A. 1990 Sep;29(5):277-80
2120839
Pathol Annu. 1982;17 (Pt 1):101-28
6750533
Hum Reprod Update. 1999 Sep-Oct;5(5):421-32
10582781
Andrologia. 2008 Apr;40(2):76-80
18336454
Asian J Androl. 2004 Dec;6(4):305-11
15546021
Arch Pathol Lab Med. 2002 Jan;126(1):64-9
11800649
Fertil Steril. 2002 Jan;77(1):76-82
11779594
Eur Urol. 1991;19(3):204-8
1855525
Drugs. 2002;62(12):1741-53
12149044
Urology. 2000 Jun;55(6):931-3
10840112
Chem Immunol Allergy. 2005;88:1-14
16129933
Urology. 2005 Nov;66(5):935-40
16286098
Sex Transm Dis. 1984 Jul-Sep;11(3):173-81
6390741
Andrologia. 2008 Apr;40(2):84-91
18336456
Andrologia. 2008 Apr;40(2):92-6
18336457
BJU Int. 2006 Jan;97(1):138-41
16336344
Eur Urol. 2009 Oct;56(4):708-15
18715698